Advicenne SA (ADVIC)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Advicenne SA (ADVIC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011885
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Advicenne SA (Advicenne) is a developer of pediatric medicines. The company’s product portfolio includes ADV6209, a liquid formulation of a benzodiazepine for moderate sedation and anesthetic premedication; ADV7103, a formulation in the form of micro-tablets for renal tubulopathies. It offers its products for the treatment of neurological diseases and renal disorders in children. Advicenne also provides products for the treatment epilepsy, anesthesia and dystonia. The company provides clinical research services by using statistical tools, approaches of meta-analysis and data modeling and simulation. It works in partnership with other pharmaceutical companies. The company operates through its offices in Nimes, Montbonnot and Paris, France. Advicenne is headquartered in Nimes, France.

Advicenne SA (ADVIC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advicenne SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Advicenne SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advicenne SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Advicenne Pharma Raises USD17 Million in Financing Round 10
Advicenne Pharma To Raise Funds Through Venture Financing 11
Advicenne Pharma Secures US$7.25 Million In Venture Financing 12
Licensing Agreements 13
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Equity Offering 14
Advicenne Pharma Raises USD32 Million in IPO of Shares 14
Asset Transactions 15
Primex Pharma Acquires Rights to Oral Pharma Candidate for Pediatric Anesthesiology from Advicenne 15
Advicenne SA – Key Competitors 16
Advicenne SA – Key Employees 17
Advicenne SA – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Corporate Communications 19
Sep 01, 2016: Advicenne Appoints Ludovic Robin as Chief Business & Strategy Officer 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Advicenne SA, Pharmaceuticals & Healthcare, Key Facts 2
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Advicenne SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Advicenne SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Advicenne SA, Deals By Therapy Area, 2011 to YTD 2017 8
Advicenne SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Advicenne Pharma Raises USD17 Million in Financing Round 10
Advicenne Pharma To Raise Funds Through Venture Financing 11
Advicenne Pharma Secures US$7.25 Million In Venture Financing 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Advicenne Pharma Raises USD32 Million in IPO of Shares 14
Primex Pharma Acquires Rights to Oral Pharma Candidate for Pediatric Anesthesiology from Advicenne 15
Advicenne SA, Key Competitors 16
Advicenne SA, Key Employees 17
Advicenne SA, Other Locations 18

★海外企業調査レポート[Advicenne SA (ADVIC)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evine Live Inc.
    Evine Live Inc. - Strategy, SWOT and Corporate Finance Report Summary Evine Live Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Newfield Exploration Company (NFX)-石油・ガス分野:企業M&A・提携分析
    Summary Newfield Exploration Company (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The com …
  • Universiteit Utrecht-製薬・医療分野:企業M&A・提携分析
    Summary Universiteit Utrecht (Universiteit Utrecht) is a research university that offers education programs. The university offers bachelors, master's, honor education, education for professionals, online education, training and other education courses. Its research areas include earth and sustainab …
  • EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析
    Summary EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comp …
  • Global Voice Group SA:企業の戦略的SWOT分析
    Global Voice Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • NeuroDerm Ltd (NDRM)-医療機器分野:企業M&A・提携分析
    Summary NeuroDerm Ltd (NeuroDerm) is a clinical stage pharmaceutical company that focuses on the development of drugs for the treatment of Parkinson’s disease and central nervous system (CNS) disorders through proprietary reformulations of its existing drugs. The company’s levodopa/carbidopa (LD/CD) …
  • Syngen Biotech Co Ltd (8279)-製薬・医療分野:企業M&A・提携分析
    Summary Syngen Biotech Co Ltd (Syngen), a part of Standard Chem& Pharm Co Ltd, is a biotechnology company that specializes in strain identification, micro-organism fermentation, recovery, and purification. The company research, develops, manufactures and distributes active pharmaceutical ingredients …
  • Nichii Gakkan Co Ltd (9792):企業の財務・戦略的SWOT分析
    Nichii Gakkan Co Ltd (9792) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Ekarat Engineering (Public) Co Ltd (AKR):企業の財務・戦略的SWOT分析
    Ekarat Engineering (Public) Co Ltd (AKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Fairfax Financial Holdings Limited:企業のM&A・事業提携・投資動向
    Fairfax Financial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fairfax Financial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • KEC International Ltd:企業の戦略・SWOT・財務情報
    KEC International Ltd - Strategy, SWOT and Corporate Finance Report Summary KEC International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Numedii Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Numedii Inc (Numedii) is a life science technology company that discovers and develops new drug candidates by translating life sciences big data into therapies. The company uses life sciences big data technology to discover and de-risk molecular entities based on therapeutically relevant bio …
  • Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY):企業の財務・戦略的SWOT分析
    Dyo Boya Fabrikalari Sanayi ve Tic. A.S. (DYOBY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Raschig GmbH:企業の戦略的SWOT分析
    Raschig GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Iovance Biotherapeutics Inc (IOVA):企業の財務・戦略的SWOT分析
    Iovance Biotherapeutics Inc (IOVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Fubon Insurance Co., Ltd.:企業の戦略的SWOT分析
    Fubon Insurance Co., Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • Westar Energy Inc (WR):企業の財務・戦略的SWOT分析
    Westar Energy Inc (WR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Melbana Energy Ltd (MAY):石油・ガス:M&Aディール及び事業提携情報
    Summary Melbana Energy Ltd (Melbana), formerly MEO Australia Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration and development of oil and gas properties. Its projects include Cuba – Block 9 PSC, Taranaki Basin, Petrel Sub-Basin Exploration, T …
  • Holding Slovenske elektrarne d.o.o.:企業の戦略的SWOT分析
    Holding Slovenske elektrarne d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆